Chirmule N - Search Results

1

Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact.

Tatarewicz SM, Mytych DT, Manning MS, Swanson SJ, Moxness MS, Chirmule N. Tatarewicz SM, et al. Among authors: chirmule n. Bioanalysis. 2014 Jun;6(11):1509-23. doi: 10.4155/bio.14.114. Bioanalysis. 2014. PMID: 25046051 Review.

2

Assessing specificity for immunogenicity assays.

Swanson SJ, Chirmule N. Swanson SJ, et al. Among authors: chirmule n. Bioanalysis. 2009 Jun;1(3):611-7. doi: 10.4155/bio.09.41. Bioanalysis. 2009. PMID: 21083156 Review.

3

Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment.

Bautista AC, Wullner D, Moxness M, Swanson SJ, Chirmule N, Jawa V. Bautista AC, et al. Among authors: chirmule n. Bioanalysis. 2010 Apr;2(4):721-31. doi: 10.4155/bio.10.24. Bioanalysis. 2010. PMID: 21083270

4

Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates.

Hoofring SA, Lopez R, Hock MB, Kaliyaperumal A, Patel SK, Swanson SJ, Chirmule N, Starcevic M. Hoofring SA, et al. Among authors: chirmule n. Bioanalysis. 2013 May;5(9):1041-55. doi: 10.4155/bio.13.10. Bioanalysis. 2013. PMID: 23641695

5

A step-wise approach for transfer of immunogenicity assays during clinical drug development.

Tatarewicz S, Moxness M, Weeraratne D, Zhou L, Hale M, Swanson SJ, Chirmule N. Tatarewicz S, et al. Among authors: chirmule n. AAPS J. 2009 Sep;11(3):526-34. doi: 10.1208/s12248-009-9130-3. Epub 2009 Jul 22. AAPS J. 2009. PMID: 19626442 Free PMC article.

6

Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects.

Jawa V, Hokom M, Hu Z, El-Abaadi N, Zhuang Y, Berger D, Gupta S, Swanson SJ, Chirmule N. Jawa V, et al. Among authors: chirmule n. Ann Hematol. 2010 Jul;89 Suppl 1(Suppl 1):75-85. doi: 10.1007/s00277-010-0908-2. Epub 2010 Feb 13. Ann Hematol. 2010. PMID: 20155267 Free PMC article.

7

Identification and inhibition of drug target interference in immunogenicity assays.

Zhong ZD, Dinnogen S, Hokom M, Ray C, Weinreich D, Swanson SJ, Chirmule N. Zhong ZD, et al. Among authors: chirmule n. J Immunol Methods. 2010 Apr 15;355(1-2):21-8. doi: 10.1016/j.jim.2010.02.008. Epub 2010 Feb 24. J Immunol Methods. 2010. PMID: 20188106

8

Detection of anti-ESA antibodies in human samples from PRCA and non-PRCA patients: an immunoassay platform comparison.

Barger TE, Kuck AJ, Chirmule N, Swanson SJ, Mytych DT. Barger TE, et al. Among authors: chirmule n. Nephrol Dial Transplant. 2012 Feb;27(2):688-93. doi: 10.1093/ndt/gfr213. Epub 2011 May 19. Nephrol Dial Transplant. 2012. PMID: 21602184

9

Stratification of antibody-positive subjects by antibody level reveals an impact of immunogenicity on pharmacokinetics.

Zhou L, Hoofring SA, Wu Y, Vu T, Ma P, Swanson SJ, Chirmule N, Starcevic M. Zhou L, et al. Among authors: chirmule n. AAPS J. 2013 Jan;15(1):30-40. doi: 10.1208/s12248-012-9408-8. Epub 2012 Oct 9. AAPS J. 2013. PMID: 23054969 Free PMC article. Clinical Trial.

10

Measurement of anti-erythropoiesis-stimulating agent IgG4 antibody as an indicator of antibody-mediated pure red cell aplasia.

Weeraratne DK, Kuck AJ, Chirmule N, Mytych DT. Weeraratne DK, et al. Among authors: chirmule n. Clin Vaccine Immunol. 2013 Jan;20(1):46-51. doi: 10.1128/CVI.00435-12. Epub 2012 Oct 31. Clin Vaccine Immunol. 2013. PMID: 23114696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters